Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$36.71 - $44.15 $121,143 - $145,695
-3,300 Reduced 4.51%
69,900 $2.91 Million
Q1 2023

May 15, 2023

SELL
$36.81 - $48.12 $40,491 - $52,932
-1,100 Reduced 1.48%
73,200 $3.02 Million
Q4 2022

Feb 13, 2023

SELL
$35.68 - $44.71 $2.09 Million - $2.62 Million
-58,600 Reduced 44.09%
74,300 $3.06 Million
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $68,016 - $86,432
-1,600 Reduced 1.19%
132,900 $5.82 Million
Q2 2022

Aug 11, 2022

SELL
$46.84 - $59.75 $440,296 - $561,650
-9,400 Reduced 6.53%
134,500 $6.61 Million
Q1 2022

May 11, 2022

SELL
$48.09 - $57.79 $346,248 - $416,088
-7,200 Reduced 4.77%
143,900 $8.16 Million
Q4 2021

Feb 11, 2022

SELL
$47.19 - $62.68 $3.18 Million - $4.22 Million
-67,400 Reduced 30.85%
151,100 $7.93 Million
Q3 2021

Nov 12, 2021

SELL
$56.91 - $67.81 $9.69 Million - $11.5 Million
-170,300 Reduced 43.8%
218,500 $13.1 Million
Q2 2021

Aug 10, 2021

SELL
$64.02 - $71.72 $653,004 - $731,544
-10,200 Reduced 2.56%
388,800 $26.4 Million
Q1 2021

May 14, 2021

SELL
$53.26 - $68.08 $5.09 Million - $6.5 Million
-95,500 Reduced 19.31%
399,000 $26.2 Million
Q4 2020

Feb 08, 2021

SELL
$43.41 - $56.51 $1.9 Million - $2.47 Million
-43,700 Reduced 8.12%
494,500 $27.9 Million
Q3 2020

Nov 13, 2020

SELL
$47.43 - $60.75 $4.24 Million - $5.43 Million
-89,400 Reduced 14.24%
538,200 $26.1 Million
Q2 2020

Aug 13, 2020

SELL
$43.51 - $66.59 $2.41 Million - $3.68 Million
-55,300 Reduced 8.1%
627,600 $34.9 Million
Q1 2020

May 14, 2020

SELL
$32.82 - $81.13 $3.19 Million - $7.89 Million
-97,200 Reduced 12.46%
682,900 $34.6 Million
Q3 2019

Nov 13, 2019

SELL
$55.78 - $68.08 $1.92 Million - $2.34 Million
-34,400 Reduced 4.22%
780,100 $49.4 Million
Q2 2019

Aug 14, 2019

SELL
$53.69 - $65.47 $59,059 - $72,017
-1,100 Reduced 0.13%
814,500 $47.7 Million
Q1 2019

May 14, 2019

SELL
$44.53 - $58.9 $204,838 - $270,940
-4,600 Reduced 0.56%
815,600 $46.3 Million
Q4 2018

Feb 12, 2019

SELL
$47.64 - $71.26 $709,836 - $1.06 Million
-14,900 Reduced 1.78%
820,200 $40.6 Million
Q1 2018

May 14, 2018

SELL
$46.03 - $61.28 $4,603 - $6,128
-100 Reduced 0.01%
835,100 $43.6 Million
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $44.7 Million - $56.8 Million
835,200
835,200 $46.3 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.